Evidence map›Paper›PMID 42429861›Full record

ReviewWorld journal of microbiology & biotechnology2026

Metabolic adaptations of extremophiles and their applications in environmental biotechnology.

Vladimíra Krempaská, Michaela Murgašová, Matej Vesteg

Abstract readReview
In one paragraph

Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vladimíra KrempaskáDepartment of Biology and Environmental Studies, Faculty of Natural Sciences, Matej Bel University, Tajovského 40, Banská Bystrica, 974 01, Slovakia.
Michaela MurgašováDepartment of Biology and Environmental Studies, Faculty of Natural Sciences, Matej Bel University, Tajovského 40, Banská Bystrica, 974 01, Slovakia.
Matej VestegDepartment of Biology and Environmental Studies, Faculty of Natural Sciences, Matej Bel University, Tajovského 40, Banská Bystrica, 974 01, Slovakia. matej.vesteg@umb.sk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extremophiles are microorganisms capable of surviving and thriving under extreme environmental conditions, such as high or low temperatures, extreme pH, elevated pressure or high salinity. These organisms have evolved specialized physiological and biochemical adaptations that enable them to metabolize toxic compounds that are typically lethal to microorganisms living in moderate habitats. Owing to their unique metabolic and enzymatic capabilities, extremophiles are promising candidates for degradation of hazardous pollutants in environments where other microorganisms often exhibit limited activity. This review focuses on the metabolic adaptations and current applications of extremophiles in sustainable environmental biotechnology. In contrast to other reviews focusing primarily on extremozymes or individual remediation strategies, we integrate current knowledge about extremophile physiology with emerging applications fo the removal of plastics, toxic metals (TMs) and petroleum-derived compounds, and we describe the molecular mechanisms employed by extremophiles in these processes. We also discuss current limitations and future research directions in biotechnologies based on extremophiles.

Indexed as

Adaptation, PhysiologicalBiotechnologyExtremophilesBacteriaBiodegradation, EnvironmentalEnvironmental PollutantsMetalsPetroleumEnvironmental PollutantsMetalsPetroleumBioleachingBioremediationEnvironmental biotechnologyExtremophilesExtremozymesPlastic biodegradationPollutant degradation

Identifiers

PMID42429861
PMCPMC13354681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.